Frequently Asked Questions

As with any surgical procedure, there are potential risks and complications associated with HoLEP. These can include bleeding, urinary tract infection, temporary or permanent urinary incontinence, erectile dysfunction, bladder neck contracture, and urethral stricture. However, the overall risk of complications with HoLEP is generally low.

The recovery time after HoLEP can vary from person to person. Most patients stay in the hospital for 1 to 2 days after the procedure. It may take several weeks to fully recover and return to normal activities. However, the improvement in urinary symptoms is often noticeable within the first few weeks.

Yes, anesthesia is used during HoLEP. It can be performed under general anesthesia or spinal anesthesia, depending on the patient and the surgeon's preference.

The duration of the HoLEP procedure can vary depending on the size of the prostate and the complexity of the case. On average, it may take around 1 to 2 hours.

HoLEP is a minimally invasive surgical technique that uses a holmium laser to remove prostate tissue. It offers advantages such as precise tissue removal, minimal blood loss, shorter hospital stay, faster recovery, and reduced risk of complications compared to traditional open prostatectomy or transurethral resection of the prostate (TURP).

HoLEP is performed to treat benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland that can cause urinary symptoms and obstruction. The procedure aims to remove excess prostate tissue to relieve urinary symptoms and improve urine flow.

UroLift has demonstrated long-term effectiveness in improving urinary symptoms and maintaining quality of life for many patients with BPH. Clinical studies have shown sustained improvement in symptoms for up to 5 years. However, the longevity of the effect may vary among individuals, and some patients may require additional treatments or interventions in the future if their symptoms worsen over time.

The need for medication after UroLift varies from person to person. Some patients may experience sufficient symptom relief with UroLift and may be able to reduce or discontinue their medication for BPH. However, the decision to adjust or stop medication should be made in consultation with your healthcare provider based on your individual situation.

UroLift is designed to preserve sexual function. Unlike some other treatments for BPH, such as transurethral resection of the prostate (TURP), UroLift has a lower risk of causing sexual side effects such as erectile dysfunction or retrograde ejaculation. However, individual experiences may vary, and it's important to discuss any concerns about sexual function with your healthcare provider.

UroLift is generally well-tolerated by patients. The procedure is usually performed under local anesthesia, which numbs the surgical area, reducing discomfort during the procedure. Some patients may experience mild discomfort or temporary urinary symptoms after the procedure, but these symptoms typically resolve within a few days.